// App-Quantinova.ai

e14133 : Reimbursement recommendations for cancer drugs supported by phase II evidence in Canada.

Researchers

Presenter

  • Regina Li

Principal Investigators

  • Helen Mai

  • Kaitlyn Chiasson

  • Maureen E. Trudeau

  • Kelvin K. Chan

  • Matthew C. Cheung

Medical Centers

  • University of Toronto, Toronto, ON, Canada

  • Pan-Canadian Oncology Drug Review, Canadian Agency for Drugs and Technologies in Health, Toronto, ON, Canada

  • CADTH, Ottawa, ON, Canada

  • Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada

  • Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved